US FDA Rides Different Monograph System In Second Roundup Of Oral Phenylephrine Efficacy

“One of the things that we're particularly excited about under monograph reform is it does give us the opportunity to move things along a little bit more quickly,” says FDA Office of Nonprescription Drugs director Theresa Michele during NDAC meeting.